Related Experiment Video
Updated: Oct 18, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Relationship between vitamin D serum concentration and inflammatory bowel disease demographics: A cross-sectional
Mohammad Shehab1,2, Abdulwahab AlSayegh2, Ali H Ziyab3
1Program of Medicine, College of Medicine and Health Sciences, Abdullah Al Salem University, Khaldiya, Kuwait.
Abstract:
Vitamin D deficiency is increasingly recognized as a common comorbidity in patients with inflammatory bowel disease (IBD), potentially influencing immune regulation and disease outcomes. Despite high rates of vitamin D deficiency reported globally, data from the Middle East remain scarce. This study aimed to evaluate the relationship between vitamin D concentration and the demographics of patients with IBD. We conducted a cross-sectional comparative study utilizing an IBD clinical cohort from a tertiary care center and a separate, previously published population-based control cohort. Serum 25-hydroxyvitamin D [25(OH)D] concentrations were measured in 184 patients with IBD (122 Crohn disease, 62 ulcerative colitis) and 410 controls without IBD. Associations between vitamin D concentrations, demographics, and disease subtype were assessed using chi-squared tests, Wilcoxon rank-sum tests, and logistic regression to calculate adjusted odds ratios (aOR). IBD patients had significantly lower median vitamin D concentrations than controls (18.0 vs 31.0 nmol/L, P < .001), with 78.8% exhibiting severe deficiency (<25 nmol/L). Severe vitamin D deficiency was associated with higher odds of IBD in both sexes, with a stronger association among females (aOR 10.57, 95% CI: 5.33-20.96) than males (aOR 4.64, 95% CI: 2.57-8.37; P-interaction = .021). Vitamin D concentrations were significantly lower in Crohn disease compared to ulcerative colitis (16.5 vs 22.0 nmol/L, P = .003), though no associations were found with CD phenotype, and UC extent showed no association overall. Vitamin D deficiency is highly prevalent among patients with inflammatory bowel disease, particularly in those with Crohn disease and in females, underscoring both systemic disease-related associations and sex-specific vulnerability. Larger, prospective, multicenter studies are warranted to further elucidate the associated factors and clinical implications of vitamin D deficiency in this population.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction

